Publication | Closed Access

Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131i] metaiodobenzylguanidine: Implications for the targeted radiotherapy of neuroblastoma

Enhanced Tumour UptakeVitro RadiotoxicityRadiation TherapyMedicinePharmacologyTargeted RadiotherapyRadiopharmaceuticalsAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyNuclear MedicineCancer Research